Cervical cancer research proposal

August 2, FDA has approved pembrolizumab Keytruda for some women with advanced cervical cancer and some patients with primary mediastinal large B-cell lymphoma PMBCLa rare type of non-Hodgkin lymphoma. October 5, By comparing the genomes of women infected with a high-risk type of human papillomavirus HPVresearchers have found that a precise DNA sequence of a viral gene is associated with cervical cancer. TCGA study identifies genomic features of cervical cancer Posted:

Cervical cancer research proposal

Spread to adjacent pelvic organs Spread to distant organs Adapted from FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet ; 2: Laboratory surveys from the mids from the College of American Pathologists suggest that more than 1 million women are diagnosed each year with low-grade cervical intraepithelial lesions and that approximatelyare diagnosed with high-grade cervical cancer precursor lesions.

Together we WILL end Breast Cancer | Florida Breast Cancer Foundation

In recent years, an increased understanding of HPV biology has modified our understanding of cervical carcinogenesis and the significance of different grades of precursor lesions. Additionally, some pathologists favor employing two additional tiers of HPV-related intraepithelial lesions: However, it appears that the interaction between HPV and the cervical epithelium is actually dichotomous.

Infection of the cervical epithelium may result in either transient productive infection with viral proliferation, or in persistent infection with progression to precancer. The latter is mediated primarily by two viral proteins, E6 and E7. The early viral protein E6 binds to p53 protein in the host epithelial cell, resulting in its degradation and loss of its normal functions promoting growth arrest and apoptosis.

The early viral protein E7 binds to pRb protein in the host epithelial cell, resulting in release of the DNA replication-promoting transcription factor E2F.

Disruption of the early viral protein E2 by viral integration into the host genome also plays a role in cell cycle disruption by causing increased expression of E6 and E7.

These terms had previously been used only for cytology interpretation under the Bethesda system. Histologic LSIL corresponds to CIN 1, including both lesions with loss of maturation in the lower third of the epithelium mild dysplasia and those with HPV cytopathic effect without dysplasia.

Firstly, a dichotomous terminology better corresponds to the dichotomous biology of HPV infection. Secondly, switching to a two-tiered system improves diagnostic reproducibility.

CIN 1 and 3 has been elucidated. This practice will allow clinicians to continue to have the option for more conservative management of this lesion in younger patients. Low-grade squamous intraepithelial lesion Low-grade squamous intraepithelial lesion LSIL in the cervix is most commonly flat, but may rarely be exophytic Fig.

Condyloma acuminatum is an exophytic papillary lesion with viral cytopathic effect but no significant dysplasia. Although the LAST guidelines recommend classifying condyloma acuminatum as LSIL, with an optional parenthetical qualifier, an argument can be made that it is important to distinguish condyloma acuminatum from flat LSIL.

Similar changes can be seen with reactive epithelial change in the setting of inflammation, as well as with degenerative change as is frequently encountered in detached epithelial fragments in cervical biopsy and endocervical curettage specimens.

Careful assessment for typical cytologic features and for the presence of potentially confounding factors should therefore be undertaken. Low-grade squamous intraepithelial lesion LSIL. A Condyloma acuminatum shows papillomatosis, acanthosis, parakeratosis, and hyperkeratosis.

Each papillary frond has a tiny blood vessel at its core. Dysplasia may be present in up to the lower one third of the epithelium. Hematoxylin-eosin stain, red bar: High-grade squamous intraepithelial lesion High-grade squamous intraepithelial lesion HSIL is a precancerous lesion characterized by an abnormal parabasal-like cell proliferation with loss of polarity, overlapping nuclei, high nuclear-to-cytoplasmic ratio, increased mitoses, dyskeratosis, apoptosis, hyperchromasia, and significant nuclear atypia.

Viral cytopathic effect may or may not be present. The immature and atypical epithelium extends to at least the middle third of the epithelium and may involve up to the full thickness of the epithelium. Though both are considered preneoplastic lesions with a risk for progression, the rates of regression, persistence, and progression differ for these two lesion grades.

CIN 2 diagnostic uncertainty. Diffuse, strong, block positivity for p16 in at least the lower third of the epithelium supports the diagnosis of HSIL, while all other staining patterns negative, focal, patchy favor a diagnosis of LSIL or less Fig.

High-grade squamous intraepithelial lesion HSIL. Dysplastic squamous cells in the basal two-thirds of the epithelium; the upper half of the epithelium shows koilocytic atypia; B CIN 3: Dysplastic squamous cells present throughout the full thickness of the epithelium; koilocytic atypia is present in the superficial layers.

A Diffuse strong p16 expression in area of atypical attenuated squamous epithelium, supporting diagnosis of HSIL. In contrast to LSIL, true in situ neoplasia is a monoclonal proliferations of cells that show evidence of genetic instability.

However, in young women aged 21—24 years with CIN 2 specifically, observation is preferred. The discussion below focuses on p16 and Ki, the most widely used in clinical practice. Due to the inverse relationship between p16 and pRb, binding of the viral protein E7 to the host cell pRb results in increased expression of p Additionally, given the expression of p16 in a significant percentage of LSILs, some caution is necessary in adhering to the new guidelines recommending use of p16 to adjudicate CIN 1 vs.

CIN 2 diagnostic uncertainty, and some authors disagree with the use of p16 in this setting due to the risk of overdiagnosis and overtreatment of LSIL.

The use of p16 increases interobserver agreement and individual pathologist accuracy.Related Post of Cervical cancer research proposal pdf online physics homework brainfuse research paper terminology recommendation about social media research paper on.

The Chao Family Comprehensive Cancer Center Research Programs have been restructured to reflect the following: Breast and Cervical Cancer Early Detection Program.

Proposal for the Development of a Breast & Gynecologic Cancer Research Program at the Chao Family NCI-Designated Comprehensive Cancer Center at UC Irvine.

Rates of cervical cancer in developed countries have decreased dramatically because of cytologic screening and DNA testing for high-risk human papillomavirus (HPV) types.

Cervical cancer is when abnormal cells in the lining of the cervix grow in an uncontrolled way. The cervix is the lower part of the womb.

It is . Research Proposal on Cancer January 4, writer Research Proposals 0 Cancer is not a disease of a certain organ but is a system of diseases, which can influence any part of the human organism and develop there.

Nov 16,  · New ways to prevent and treat cancer of the cervix are being researched. Some of the promising new developments include the following: During surgery for cervical cancer, lymph nodes in the pelvis may be removed to check for cancer spread.

Cervical cancer research proposal

Instead of removing many lymph nodes, a technique called.

What's New in Cervical Cancer Research and Treatment?